EICHOR
● Completed
Ground-Breaking Electroporation-based Intervention for PERSistent Atrial Fibrillation Treatment (BEAT PERS-AF)
Condition: Atrial Fibrillation · Sponsor: University Hospital, Bordeaux
About this study
BEAT AF is a randomized controlled trial aiming to assess the efficacy and the safety of pulsed field energy in persistent AF ablation
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (9)
| Medical University of Graz | Graz, Austria | — |
| AZ Sint-Jan Brugge-Oostende | Bruges, Belgium | — |
| Homolka Hospital | Prague, Czechia | — |
| Institute for Clinical and Experimental Medicine | Prague, Czechia | — |
| CHU Bordeaux | Pessac, France | — |
| CHU Toulouse | Toulouse, France | — |
| Clinique Pasteur, Toulouse | Toulouse, France | — |
| Cardiovascular Center Bad Neustadt | Bad Neustadt an der Saale, Germany | — |
| Deutsches Herzzentrum München | Munich, Germany | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05418725